Tag: KAIST
Top News
Sam Chun Dang Pharm Soars to Daily Limit After Securing U.S....
Sam Chun Dang Pharm's stock surged after FDA's Pre-ANDA response for its generic oral semaglutide, marking a key milestone for market entry.
- Our Sponsors Ad -
